Spero Therapeutics SPRO 深 沪
交易中 04-23 12:21:50 美东时间
1.449
+0.044
+3.13%
华盛通- 最 高1.4795
- 今 开1.40
- 成交量 5.26万股
- 最 低 1.40
- 昨 收 1.405
- 总市值 7638.59万
- 52周最高 1.995
- 市盈率 静 3.37
- 换手率 0.10%
- 52周最低 0.99
- 委 比 98.90%
- 总股本 5271.63万
- 历史最高 23.639
- 量 比 0.51
- 振 幅 5.66%
- 历史最低 0.68
- 每 手 1
- 风险率 0.23%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Cantor Fitzgerald Reiterates Overweight on Spero Therapeutics
Cantor Fitzgerald analyst Louise Chen reiterates Spero Therapeutics (NASDAQ:SPRO) with a Overweight.
04-04 21:45
Earnings Scheduled For March 13, 2024
Companies Reporting Before The Bell • Sangamo Therapeutics (NASDAQ:SGMO) is likely to report quarterly loss at $0.26 per share on revenue of $8.10 million.
03-13 18:15
在Spero Therapeutics, Inc.（纳斯达克股票代码：SPRO）股价上涨27％看起来合理之前，需要增加收入
Spero Therapeutics, Inc. (NASDAQ:SPRO) shares have continued their recent momen...
03-12 06:35
Spero Therapeutics 将出席考恩第 44 届年度医疗保健会议
CAMBRIDGE, Mass., Feb. 26, 2024 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (N...
02-26 21:05
HALOZYME REPORTS FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL AND OPERATING RESULTS
Reiterating 2024 Financial Guidance: Total Revenue of $915-985 Million, Representing YOY Growth of 10-19%, Adjusted EBITDA of $535-585 Million, Representing YOY Growth of 26- 37% and Non-GAA...
02-21 05:01
AI助力生命科学领域，2023年度十大创新产品揭晓
人工智能（AI）在生命科学领域产生了重大影响，不仅用于数据分析和药物研发，还应用于疾病诊断和治疗。经过评选活动，揭晓了2023年的十大创新产品，包括Orbit...
02-08 15:13
Don't Ignore The Insider Selling In Spero Therapeutics
Investors may wish to note that the Co-Founder & Chairman of the Board of S...
02-08 06:00
Recap: Spero Therapeutics Q3 Earnings
Spero Therapeutics (NASDAQ:SPRO) reported its Q3 earnings results on Monday, No...
2023-11-14 05:20
Earnings Outlook For Spero Therapeutics
Spero Therapeutics (NASDAQ:SPRO) is set to give its latest quarterly earnings r...
2023-11-11 01:02
Genmab Announces Q3 Net Sales of $2.5B for DARZALEX (Daratumumab)
Genmab A/S (NASDAQ:GMAB) announced today that worldwide net trade sales of DARZALEX® (daratumumab), including sales of the subcutaneous (SC) product (daratumumab and hyaluronidase-fihj, sold under
2023-10-17 18:29
